Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
NCT06375083
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
NCT03442699
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
NCT04324944
Effectiveness and Implementation of Brief Cognitive Behavioral Therapy in CBOCs
NCT02466126
Enhanced Brief CBT for Suicidal Inpatients With Mood Disorders
NCT07072845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as Usual
Treatment as usual (TAU) outpatient care will consist of existing outpatient clinical practices utilized in the Mental Health Clinic.
No interventions assigned to this group
CAMS
First, as discussed above, suicidality is the focus of treatment rather than one of many symptoms being treated. Second is the emphasis on patient and therapist collaborating on treatment rather than the therapist dictating how therapy progresses. Beyond those two basic tenets, each therapist is free to utilize their current clinical skills to conduct psychotherapy.
CAMS
First, as discussed above, suicidality is the focus of treatment rather than one of many symptoms being treated. Second is the emphasis on patient and therapist collaborating on treatment rather than the therapist dictating how therapy progresses. Beyond those two basic tenets, each therapist is free to utilize their current clinical skills to conduct psychotherapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAMS
First, as discussed above, suicidality is the focus of treatment rather than one of many symptoms being treated. Second is the emphasis on patient and therapist collaborating on treatment rather than the therapist dictating how therapy progresses. Beyond those two basic tenets, each therapist is free to utilize their current clinical skills to conduct psychotherapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Over the age of 18 years.
3. New or returning patients to the VA MHC.
4. Living within the larger Denver metropolitan region during the duration of the treatment.
5. Willing to travel to the ECHCS Denver VAMC at times other than scheduled therapy appointments to complete follow-up assessment measures.
Exclusion Criteria
2. Imminent suicidality with the need for immediate psychiatric hospitalization, as defined above in the Background section, at the time of MH intake.
3. Current involuntary status for psychiatric hospitalization.
4. Inability to adequately respond to questions regarding the informed consent procedure. See Special Consent Issues section below.
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
The Catholic University of America
OTHER
VA Eastern Colorado Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
VISN 19 Mental Illness Research, Education, and Clinical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa A Brenner, PhD
Role: PRINCIPAL_INVESTIGATOR
VISN 19 MIRECC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Visn 19 Mirecc
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-1058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.